Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 125-132 , February 2010

Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression

  • Y.-M. Yu

      Affiliations

    • Department of Nutrition and Health Sciences, Chang Jung Christian University, 396 Chang Jung Rd., Sec. 1, Kway Jen, Tainan 71101, Taiwan
    • Corresponding Author InformationCorresponding author. Fax: +886 6 2785663.
  • ,
  • H.-C. Lin

      Affiliations

    • Department of Nutrition, China Medical University, Taichung, Taiwan

Received 15 August 2008 ,Revised 27 February 2009 ,Accepted 4 March 2009.

References 

  1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809
  2. Sasaguri Y, Murahashi N, Sugama K, Kato S, Hiraoka K, Satoh T, et al. Development-related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Lab Invest. 1994;71:261–269
  3. Woessner JF. Matrix metalloproteinasses and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145–2154
  4. Birkedal-Hansen H, Moore W, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4:197–250
  5. Fabunmi RP, Baker AH, Murray EJ, Booth RG, Newby AC. Divergent regulation by growth factors and cytokines of 95kDa and 72kDa gelatinases and tissue inhibitors of metalloproteinases-1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem J. 1996;315:335–342
  6. Kutuk O, Basaga H. Inflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med. 2003;9:549–557
  7. Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-κB and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol. 2000;20:83–88
  8. Baeuerle PA. The inducible transcription activator NFκB: regulation by distinct protein subunits. Biochim Biophys Acta. 1991;1072:63–80
  9. Bond M, Chase AJ, Baker AH, Newby AC. Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res. 2001;50:556–565
  10. Cikrikci S, Mozioglu E, Yilmaz H. Biological activity of curcuminoids isolated from Curcuma longa. Rec Nat Prod. 2008;2:19–24
  11. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397–1421
  12. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78:2081–2087
  13. Yamaguchi T, Takamura H, Matoba T, Terao J. HPLC method for evaluation of the free radical-scavenging activity of foods by using 1,1-dipheny-2-picrylhydrazyl. Biosci Biotechnol Biochem. 1998;62:1201–1204
  14. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Miller AA. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 1993;84:407–412
  15. Mackness MI, Durringtom PN. Lipoprotein separation & analysis for clinical studies. In:  Converse CA,  Skinner ER editor. Lipoprotein analysis: a practical approach. Oxford: IRL Press; 1992;p. 1–42
  16. Chen YH, Lin SJ, Chen JW, Ku HH, Chen YL. Magnolol attenuates VCAM-1 expression in vitro in TNF-α-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol. 2002;135:37–47
  17. Demeule M, Brossard M, Page M, Gingras D, Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta. 2000;1478:51–60
  18. Bedoui J, Oak MH, Anglard P, Schini-Kerth VB. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc Res. 2005;67:317–325
  19. Kim YM, Kim KE, Koh GY, Ho YS, Lee KJ. Hydrogen peroxide produced by Angiopoietin-1 mediates angiogenesis. Cancer Res. 2006;66:6167–6174
  20. Strimpakos AS, Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal. 2008;10:511–546
  21. Ahsan H, Parveen N, Khan NU, Hadi SM. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact. 1999;121:161–175
  22. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21:2895–2900
  23. Baeuerle PA, Baltimore D. IκB: a specific inhibitor of the NFκB transcription factor. Science. 1988;242:540–546
  24. Muller JM, Rupec RA, Baeuerle PA. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods. 1997;11:301–312
  25. Sato H, Seiki M. Regulatory mechanism of 92-kDa Type-IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene. 1993;8:395–405
  26. Fini ME, Bartlett JD, Matsubara M. The rabbit gene for 92-kDa matrix metalloproteinase: role of AP1 and AP2 in cell type-specific transcription. J Biol Chem. 1994;269:28620–28628
  27. Bond M, Chase AJ, Baker AH, Newby AC. Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res. 2001;50:556–565
  28. Kim CH, Moon SK. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G1-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells. Arch Biochem Biophys. 2005;435:264–272
  29. Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cellcycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun. 2003;301:1069–1078
  30. Yu YM, Lin HC, Chang WC. Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9. Br J Nutr. 2008;100:731–738

PII: S0939-4753(09)00058-1

doi: 10.1016/j.numecd.2009.03.001

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 125-132 , February 2010